相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations
Hsuan-Ping Chang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease
Ye Xiong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Age-Related Changes in Pediatric Physiology: Quantitative Analysis of Organ Weights and Blood Flows Age-Related Changes in Pediatric Physiology
Hsuan Ping Chang et al.
AAPS JOURNAL (2021)
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study
Ryan S. Funk et al.
PEDIATRIC RHEUMATOLOGY (2021)
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease
Laura E. Bauman et al.
INFLAMMATORY BOWEL DISEASES (2020)
Factors contributing to the systemic clearance of infliximab with long-term administration in Japanese patients with Crohn's disease: Analysis using population pharmacokinetics
Katsuyoshi Matsuoka et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2020)
Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants
Paul R. V. Malik et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations
Dwight A. Winter et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
Zaid H. Temrikar et al.
PEDIATRIC DRUGS (2020)
Development and Application of a Physiologically-Based Pharmacokinetic Model to Predict the Pharmacokinetics of Therapeutic Proteins from Full-term Neonates to Adolescents
Xian Pan et al.
AAPS JOURNAL (2020)
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
Sumit Basu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Model-Aided Adults-to-Children Pharmacokinetic Extrapolation and Empirical Body Size-Based Dosing Exploration for Therapeutic Monoclonal Antibodies-Is Allometry a Reasonable Choice?
Yan Xu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans
Shan Chung et al.
MABS (2019)
Optimising infliximab induction dosing for patients with ulcerative colitis
Erwin Dreesen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn's Disease
Ben Kang et al.
JOURNAL OF CROHNS & COLITIS (2019)
Responsive Antibody Conjugates Enable Quantitative Determination of Intracellular Bond Degradation Rate
Michelle R. Sorkin et al.
CELL CHEMICAL BIOLOGY (2019)
Physiologically-Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
Paul R. Malik et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Pediatric physiology in relation to the pharmacokinetics of monoclonal antibodies
Paul Malik et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Modeling Immunization To Infliximab in Children With Crohn's Disease Using Population Pharmacokinetics: A Pilot Study
Antoine Petitcollin et al.
INFLAMMATORY BOWEL DISEASES (2018)
A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease
Travis Piester et al.
INFLAMMATORY BOWEL DISEASES (2018)
Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis
David Kevans et al.
JOURNAL OF CROHNS & COLITIS (2018)
Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition
Dany Turner et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn Disease
Adam Frymoyer et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Population PBPK modelling of trastuzumab: a framework for quantifying and predicting inter-individual variability
Paul R. V. Malik et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2017)
Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived Products
Iftekhar Mahmood
AMERICAN JOURNAL OF THERAPEUTICS (2016)
Clinical laboratory application of a reporter-gene assay for measurement of functional activity and neutralizing antibody response to infliximab
Igor Y. Pavlov et al.
CLINICA CHIMICA ACTA (2016)
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Niels Vande Casteele et al.
GASTROENTEROLOGY (2015)
Challenges and Considerations for Development of Therapeutic Proteins in Pediatric Patients
Yi Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease
Daniel R. Hoekman et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships of Monoclonal Antibodies in Children
Helena Edlund et al.
CLINICAL PHARMACOKINETICS (2015)
Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations
Markus Krauss et al.
PLOS ONE (2015)
Simulation of Monoclonal Antibody Pharmacokinetics in HumansUsing a Minimal Physiologically Based Model
Linzhong Li et al.
AAPS JOURNAL (2014)
Changes in Individual Drug-Independent System Parameters during Virtual Paediatric Pharmacokinetic Trials: Introducing Time-Varying Physiology into a Paediatric PBPK Model
Khaled Abduljalil et al.
AAPS JOURNAL (2014)
Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis
David Ternant et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease: A Population Pharmacokinetic Study
Iris Dotan et al.
INFLAMMATORY BOWEL DISEASES (2014)
Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease
Namita Singh et al.
INFLAMMATORY BOWEL DISEASES (2014)
Review on modeling anti-antibody responses to monoclonal antibodies
Jose David Gomez-Mantilla et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Distribution of rat neonatal Fc receptor in the principal organs of neonatal and pubertal rats
Zehua Tian et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2014)
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update
Vera Kandror Denmark et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis: Results from a Randomized, Multicenter, Open-label, Phase 3 Study
Omoniyi J. Adedokun et al.
INFLAMMATORY BOWEL DISEASES (2013)
High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis
Ajay Tambralli et al.
JOURNAL OF RHEUMATOLOGY (2013)
Rational development and utilization of antibody-based therapeutic proteins in pediatrics
Zhenhua Xu et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Serum infliximab concentrations in pediatric inflammatory bowel disease
Anssi Hamalainen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis
Jeffrey Hyams et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum
Shui-Long Wang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
Dhaval K. Shah et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
Adedigbo A. Fasanmade et al.
CLINICAL THERAPEUTICS (2011)
Nonclassical major histocompatibility complex I-like Fc neonatal receptor (FcRn) expression in neonatal human tissues
Corina Cianga et al.
HUMAN IMMUNOLOGY (2011)
Pediatric Dosing and Body Size in Biotherapeutics
Rong Shi et al.
Pharmaceutics (2010)
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Adedigbo A. Fasanmade et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Infliximab Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease
Jane C. Burns et al.
JOURNAL OF PEDIATRICS (2008)
Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice
Amit Garg et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism
Shreeram Akilesh et al.
JOURNAL OF IMMUNOLOGY (2007)
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2007)
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
Jeffrey Hyams et al.
GASTROENTEROLOGY (2007)
Clinical pharmacokinetics and use of infliximab
Ulrich Klotz et al.
CLINICAL PHARMACOKINETICS (2007)
Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease
S Candon et al.
CLINICAL IMMUNOLOGY (2006)
Development and evaluation of a generic physiologically based pharmacokinetic model for children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Lymphocyte subsets in healthy children from birth through 18 years of age: The pediatric AIDS clinical trials group P1009 study
WT Shearer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
The physiology of the lymphatic system
MA Swartz
ADVANCED DRUG DELIVERY REVIEWS (2001)
MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells
XP Zhu et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
